Suppr超能文献

用核蛋白DNA疫苗接种诱导的针对流感病毒的保护性CD4+和CD8+ T细胞。

Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA.

作者信息

Ulmer J B, Fu T M, Deck R R, Friedman A, Guan L, DeWitt C, Liu X, Wang S, Liu M A, Donnelly J J, Caulfield M J

机构信息

Department of Virus and Cell Biology, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.

出版信息

J Virol. 1998 Jul;72(7):5648-53. doi: 10.1128/JVI.72.7.5648-5653.1998.

Abstract

DNA vaccination is an effective means of eliciting both humoral and cellular immunity, including cytotoxic T lymphocytes (CTL). Using an influenza virus model, we previously demonstrated that injection of DNA encoding influenza virus nucleoprotein (NP) induced major histocompatibility complex class I-restricted CTL and cross-strain protection from lethal virus challenge in mice (J. B. Ulmer et al., Science 259:1745-1749, 1993). In the present study, we have characterized in more detail the cellular immune responses induced by NP DNA, which included robust lymphoproliferation and Th1-type cytokine secretion (high levels of gamma interferon and interleukin-2 [IL-2], with little IL-4 or IL-10) in response to antigen-specific restimulation of splenocytes in vitro. These responses were mediated by CD4+ T cells, as shown by in vitro depletion of T-cell subsets. Taken together, these results indicate that immunization with NP DNA primes both cytolytic CD8+ T cells and cytokine-secreting CD4+ T cells. Further, we demonstrate by adoptive transfer and in vivo depletion of T-cell subsets that both of these types of T cells act as effectors in protective immunity against influenza virus challenge conferred by NP DNA.

摘要

DNA疫苗接种是引发体液免疫和细胞免疫(包括细胞毒性T淋巴细胞[CTL])的有效手段。利用流感病毒模型,我们先前证明,注射编码流感病毒核蛋白(NP)的DNA可诱导主要组织相容性复合体I类限制性CTL,并使小鼠在受到致死性病毒攻击时获得交叉株保护(J. B. 厄尔默等人,《科学》259:1745 - 1749,1993年)。在本研究中,我们更详细地描述了NP DNA诱导的细胞免疫反应,其包括体外对脾细胞进行抗原特异性再刺激时出现的强烈淋巴细胞增殖和Th1型细胞因子分泌(高水平的γ干扰素和白细胞介素-2[IL-2],而IL-4或IL-10很少)。如体外T细胞亚群去除实验所示,这些反应由CD4 + T细胞介导。综上所述,这些结果表明,用NP DNA免疫可启动溶细胞性CD8 + T细胞和分泌细胞因子的CD4 + T细胞。此外,我们通过过继转移和体内T细胞亚群去除实验证明,这两种类型的T细胞均在NP DNA赋予的针对流感病毒攻击的保护性免疫中充当效应细胞。

相似文献

1
Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA.
J Virol. 1998 Jul;72(7):5648-53. doi: 10.1128/JVI.72.7.5648-5653.1998.
9
CD4+ and CD8+ mediated cellular immune response to recombinant influenza nucleoprotein.
Vaccine. 2002 Nov 1;20(31-32):3731-8. doi: 10.1016/s0264-410x(02)00355-9.

引用本文的文献

2
Opportunities and challenges for T cell-based influenza vaccines.
Nat Rev Immunol. 2024 Oct;24(10):736-752. doi: 10.1038/s41577-024-01030-8. Epub 2024 May 2.
4
Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines.
Vaccines (Basel). 2023 Nov 23;11(12):1747. doi: 10.3390/vaccines11121747.
5
Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses.
J Virol. 2023 Nov 30;97(11):e0164622. doi: 10.1128/jvi.01646-22. Epub 2023 Nov 2.
8
Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats.
Adv Nanobiomed Res. 2022 Mar;2(3). doi: 10.1002/anbr.202100122. Epub 2021 Dec 7.

本文引用的文献

2
Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells.
J Virol. 1998 Jan;72(1):882-5. doi: 10.1128/JVI.72.1.882-885.1998.
3
DNA vaccines.
Annu Rev Immunol. 1997;15:617-48. doi: 10.1146/annurev.immunol.15.1.617.
5
Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine.
Vaccine. 1997 Jan;15(1):71-8. doi: 10.1016/s0264-410x(96)00101-6.
8
DNA vaccines for bacteria and viruses.
Adv Exp Med Biol. 1996;397:49-53. doi: 10.1007/978-1-4899-1382-1_7.
9
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine.
Nat Med. 1996 Aug;2(8):893-8. doi: 10.1038/nm0896-893.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验